224 related articles for article (PubMed ID: 31552418)
21. Comparative analysis of transcriptomics based hypoxia signatures in head- and neck squamous cell carcinoma.
Tawk B; Schwager C; Deffaa O; Dyckhoff G; Warta R; Linge A; Krause M; Weichert W; Baumann M; Herold-Mende C; Debus J; Abdollahi A
Radiother Oncol; 2016 Feb; 118(2):350-8. PubMed ID: 26711490
[TBL] [Abstract][Full Text] [Related]
22. Systematic Quality Control Analysis of LINCS Data.
Cheng L; Li L
CPT Pharmacometrics Syst Pharmacol; 2016 Nov; 5(11):588-598. PubMed ID: 27796074
[TBL] [Abstract][Full Text] [Related]
23. Drug Effect Prediction by Integrating L1000 Genomic and Proteomic Big Data.
Chen W; Zhou X
Methods Mol Biol; 2019; 1939():287-297. PubMed ID: 30848468
[TBL] [Abstract][Full Text] [Related]
24. L1000CDS
Duan Q; Reid SP; Clark NR; Wang Z; Fernandez NF; Rouillard AD; Readhead B; Tritsch SR; Hodos R; Hafner M; Niepel M; Sorger PK; Dudley JT; Bavari S; Panchal RG; Ma'ayan A
NPJ Syst Biol Appl; 2016; 2():16015-. PubMed ID: 28413689
[TBL] [Abstract][Full Text] [Related]
25. The Use of Large-Scale Chemically-Induced Transcriptome Data Acquired from LINCS to Study Small Molecules.
Iwata M; Yamanishi Y
Methods Mol Biol; 2019; 1888():189-203. PubMed ID: 30519948
[TBL] [Abstract][Full Text] [Related]
26. SigCom LINCS: data and metadata search engine for a million gene expression signatures.
Evangelista JE; Clarke DJB; Xie Z; Lachmann A; Jeon M; Chen K; Jagodnik KM; Jenkins SL; Kuleshov MV; Wojciechowicz ML; Schürer SC; Medvedovic M; Ma'ayan A
Nucleic Acids Res; 2022 Jul; 50(W1):W697-W709. PubMed ID: 35524556
[TBL] [Abstract][Full Text] [Related]
27. Accurate Drug Repositioning through Non-tissue-Specific Core Signatures from Cancer Transcriptomes.
Xu C; Ai D; Shi D; Suo S; Chen X; Yan Y; Cao Y; Zhang R; Sun N; Chen W; McDermott J; Zhang S; Zeng Y; Han JJ
Cell Rep; 2018 Oct; 25(2):523-535.e5. PubMed ID: 30304690
[TBL] [Abstract][Full Text] [Related]
28. A Bayesian approach to accurate and robust signature detection on LINCS L1000 data.
Qiu Y; Lu T; Lim H; Xie L
Bioinformatics; 2020 May; 36(9):2787-2795. PubMed ID: 32003771
[TBL] [Abstract][Full Text] [Related]
29. A Library of Phosphoproteomic and Chromatin Signatures for Characterizing Cellular Responses to Drug Perturbations.
Litichevskiy L; Peckner R; Abelin JG; Asiedu JK; Creech AL; Davis JF; Davison D; Dunning CM; Egertson JD; Egri S; Gould J; Ko T; Johnson SA; Lahr DL; Lam D; Liu Z; Lyons NJ; Lu X; MacLean BX; Mungenast AE; Officer A; Natoli TE; Papanastasiou M; Patel J; Sharma V; Toder C; Tubelli AA; Young JZ; Carr SA; Golub TR; Subramanian A; MacCoss MJ; Tsai LH; Jaffe JD
Cell Syst; 2018 Apr; 6(4):424-443.e7. PubMed ID: 29655704
[TBL] [Abstract][Full Text] [Related]
30. Molecular Network-Based Drug Prediction in Thyroid Cancer.
Xu X; Long H; Xi B; Ji B; Li Z; Dang Y; Jiang C; Yao Y; Yang J
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30641858
[TBL] [Abstract][Full Text] [Related]
31. Drug response prediction by ensemble learning and drug-induced gene expression signatures.
Tan M; Özgül OF; Bardak B; Ekşioğlu I; Sabuncuoğlu S
Genomics; 2019 Sep; 111(5):1078-1088. PubMed ID: 31533900
[TBL] [Abstract][Full Text] [Related]
32. Discovery of signature genes in gastric cancer associated with prognosis.
Zhao X; Cai H; Wang X; Ma L
Neoplasma; 2016; 63(2):239-45. PubMed ID: 26774142
[TBL] [Abstract][Full Text] [Related]
33. A review of connectivity map and computational approaches in pharmacogenomics.
Musa A; Ghoraie LS; Zhang SD; Glazko G; Yli-Harja O; Dehmer M; Haibe-Kains B; Emmert-Streib F
Brief Bioinform; 2018 May; 19(3):506-523. PubMed ID: 28069634
[TBL] [Abstract][Full Text] [Related]
34. MOASL: Predicting drug mechanism of actions through similarity learning with transcriptomic signature.
Jiang L; Qu S; Yu Z; Wang J; Liu X
Comput Biol Med; 2024 Feb; 169():107853. PubMed ID: 38104518
[TBL] [Abstract][Full Text] [Related]
35. A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles.
Subramanian A; Narayan R; Corsello SM; Peck DD; Natoli TE; Lu X; Gould J; Davis JF; Tubelli AA; Asiedu JK; Lahr DL; Hirschman JE; Liu Z; Donahue M; Julian B; Khan M; Wadden D; Smith IC; Lam D; Liberzon A; Toder C; Bagul M; Orzechowski M; Enache OM; Piccioni F; Johnson SA; Lyons NJ; Berger AH; Shamji AF; Brooks AN; Vrcic A; Flynn C; Rosains J; Takeda DY; Hu R; Davison D; Lamb J; Ardlie K; Hogstrom L; Greenside P; Gray NS; Clemons PA; Silver S; Wu X; Zhao WN; Read-Button W; Wu X; Haggarty SJ; Ronco LV; Boehm JS; Schreiber SL; Doench JG; Bittker JA; Root DE; Wong B; Golub TR
Cell; 2017 Nov; 171(6):1437-1452.e17. PubMed ID: 29195078
[TBL] [Abstract][Full Text] [Related]
36. Elucidating the modes of action for bioactive compounds in a cell-specific manner by large-scale chemically-induced transcriptomics.
Iwata M; Sawada R; Iwata H; Kotera M; Yamanishi Y
Sci Rep; 2017 Jan; 7():40164. PubMed ID: 28071740
[TBL] [Abstract][Full Text] [Related]
37. Identifying the genes impacted by cell proliferation in proteomics and transcriptomics studies.
Locard-Paulet M; Palasca O; Jensen LJ
PLoS Comput Biol; 2022 Oct; 18(10):e1010604. PubMed ID: 36201535
[TBL] [Abstract][Full Text] [Related]
38. Dex-Benchmark: datasets and code to evaluate algorithms for transcriptomics data analysis.
Xie Z; Chen C; Ma'ayan A
PeerJ; 2023; 11():e16351. PubMed ID: 37953774
[TBL] [Abstract][Full Text] [Related]
39. Profiling networks of distinct immune-cells in tumors.
Clancy T; Hovig E
BMC Bioinformatics; 2016 Jul; 17(1):263. PubMed ID: 27377892
[TBL] [Abstract][Full Text] [Related]
40. Biomarker identification and trans-regulatory network analyses in esophageal adenocarcinoma and Barrett's esophagus.
Lv J; Guo L; Wang JH; Yan YZ; Zhang J; Wang YY; Yu Y; Huang YF; Zhao HP
World J Gastroenterol; 2019 Jan; 25(2):233-244. PubMed ID: 30670912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
